Skip to content
  • About us
    • About us
    • Executive commitee
    • Board of Directors
    • Scientific advisors
    • Corporate governance
    • ESG
  • myvac
    • myvac – individualized therapeutic vaccines
  • Pipeline
    • Pipeline
    • TG4050
    • TG4070
    • BT-001
    • TG6050
    • Publications and Presentations
    • Clinical trials FAQ
  • Investors
    • Investor Presentation & Contacts
    • Press releases & events
    • Financial Information
    • Stock Information
    • Annual General Meeting
  • Career
  • English
  • French
PHP Toggle Menu

Category: News-fr-en

Transgene reports business update and Q3 2021 financial position

20211104 – Transgene – Q3 Financial update EN

Published 4 November 2021
Categorized as 2021, News-fr-en, Press release

Transgene’s two innovative platforms progressing well – Financial visibility extended until end 2023

Transgene’s two innovative platforms progressing well – Financial visibility extended until end 2023

Published 22 September 2021
Categorized as 2021, Press release, News-fr-en, Press release, TG4001, TG4001, TG6002 (FR)

Transgene Announces Upcoming Investor Meetings

Transgene Announces Upcoming Investor Meetings

Published 13 September 2021
Categorized as 2021, News, News-fr-en, Press release
Get to know us

About us

myvac

Pipeline

Investors

Partnering

Company

Career

ESG

Suppliers

Contacts

Legal documents

Legal notices

Privacy Policy

Ethics and compliance

Cookie policy

  • About us
    • About us
    • Executive commitee
    • Board of Directors
    • Scientific advisors
    • Corporate governance
    • ESG
  • myvac
    • myvac – individualized therapeutic vaccines
  • Pipeline
    • Pipeline
    • TG4050
    • TG4070
    • BT-001
    • TG6050
    • Publications and Presentations
    • Clinical trials FAQ
  • Investors
    • Investor Presentation & Contacts
    • Press releases & events
    • Financial Information
    • Stock Information
    • Annual General Meeting
  • Career
  • English
  • French
Menu